Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

**IMPORTANT** The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over seven years to fund the Beau Biden Cancer Moonshot Initiative. The National Cancer Institute has released numerous funding opportunity announcements, and additional funding initiatives are anticipated. You are encouraged to visit their website for a complete and current list of funding opportunities that may be available to you.

Posted October 1, 2018

National Cancer Institute Research Specialist Award

Application Due Date(s): Letter of Intent due December 11, 2018 / Full proposal due by January 11, 2019 at 5:00 p.m. PST

How to Apply: More information can be found via the NCI website

Description: The NCI R50 Award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators. Award recipients receive salary and travel support, which can provide greater autonomy.

Applicants must have an advanced degree (e.g., Masters, Ph.D., D.V.M., D.D.S., M.D.) in an area of biomedical science or biomedical engineering and have demonstrated cancer research accomplishments in their primary discipline. Additional eligibility requirements can be found in the funding opportunity announcements.


American Cancer Society Research Scholar Grant

Application Due Date(s): October 15, 2018

How to Apply: More information can be found via the American Cancer Society website

Description: The Research Scholar Grant (RSG) supports investigator-initiated projects across the cancer research continuum. Applicants to the Cancer Control and Prevention Research Program may be at any career stage provided that the focus of their project is either Health Policy/Health Services research or Achieving Cancer Health Equity.

Awards are for up to four years, for up to $165,000 a year for direct costs, plus 20 percent allowable indirect costs. Independent investigators in the first six years of an independent research career or faculty appointment are eligible to apply. Eligibility is extended for eight years for clinician scientists who remain active in clinical care.

Posted July 18, 2018

NCI Community Oncology Research Program (NCORP) Research Bases

Application Due Date(s): Internal Proposal Deadline 07/17/2018 / Letter of Intent Deadline 07/31/2018 / Full Proposal due to agency 08/31/2018

How to Apply: More information can be found at the LSO portal page.

Description: This Funding Opportunity Announcement (FOA) solicits applications from institutions/organizations to participate as "Research Bases" for the National Cancer Institute (NCI)-supported Community Oncology Research Program (NCORP). NCORP is a community-based research network.


NIH Director's Early Independence Award

Application Due Date(s): Internal Proposal Deadline 07/31/2018 / Letter of Intent Deadline 08/27/2018 / Full Proposal due to agency 09/27/2018

How to Apply: More information can be found at the LSO portal page.

Description: The NIH Director's Early Independence Award provides an opportunity for exceptional junior scientists to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. Though most newly graduated doctoral-level researchers would benefit from post-doctoral training, a small number of outstanding junior investigators would benefit from skipping such training and launching essentially directly into an independent research career. For those select junior investigators who already have established a record of scientific innovation and research productivity and who have demonstrated unusual scientific vision and maturity, typical post-doctoral training would unnecessarily delay their entry into independent research.


Posted April 11, 2018

Leukemia and Lymphoma Society Career Development Grant

Application Due Date(s): October 2, 2018

How to Apply: For more information, visit their website

Description: Scholar Award: $110,000 per year for five years / Scholar in Clinical Research Award: $125,000 per year for five years / Special Fellow Award: $67,000 per year for two or three years / Fellow Award: $60,000 per year for three years.


Cancer Research Institute Clinic & Laboratory Integration Program (CLIP)

Application Due Date(s): November 1, 2018

How to Apply: For more information, visit their website

Description: The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.


Damon Runyon Cancer Research Foundation Physician-Scientist Training Award

Application Due Date(s): December 3, 2018

How to Apply: For more information, visit their website

Description: Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.